CAS: | 2049868-46-2 | ||||||
分子式: | C14H18N2O | ||||||
分子量: | 230.31 | ||||||
中文名称: |
| ||||||
英文名称: |
| ||||||
用途: | GSK'963是RIP1 kinase的手性小分子抑制剂,在FP结合实验中IC50值为29 nM。它对RIP1的选择性是对其他339种激酶的10,000倍以上。 |
货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||
G795034 | MACKLIN | GSK'963 | 10mM in DMSO | 598元/1ml; | 展开 | ||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||
G873074 | MACKLIN | GSK'963 | 99% | 809元/5mg; 2490元/25mg; 2988元/100mg; | 展开 | ||||||||||||||||||||||||||
储存:-20℃ 状态:粉末 | |||||||||||||||||||||||||||||||
SML2376 | Sigma-Aldrich | GSK′963 | ≥98% (HPLC) | 1023.54元/5 MG; 4128.87元/25 MG; | 展开 | ||||||||||||||||||||||||||
产品说明 生化/生理作用 GSK′963 (GSK′963A) is a brain-penetrant, highly potent and selective ATP site-targeting receptor-interacting protein 1 kinase (RIP1; RIPK1) inhibitor (IC50 = 0.8-8 nM with 50 μM ATP; IC50 >10 μM against RIPK2/3/5 and 335 other kinases) that protects against TNFα/zVAD-induced necroptosis (EC50 = 1/4 nM in mouse L929/human U937 cultures) and blocks Y. pestis-induced death of murine fetal liver macrophages (1 μM). GSK′963 prevents lethal hypothermia by acute sterile shock (2 mg/kg i.p. 15 min prior to TNFα/zVAD i.v.) and protects against acute neuronal death upon autologous blood intracerebral hemorrhage induction in mice in vivo (25 mg/kg/3 hr i.p.). 基本信息
产品性质
安全信息
|